This trial is testing whether a drug that helps blood flow can also help reduce fat storage in obese people.
2 Primary · 4 Secondary · Reporting Duration: 12 weeks
Active Control
Non-Treatment Group
100 Total Participants · 2 Treatment Groups
Primary Treatment: Tadalafil · Has Placebo Group · Phase 2
Age 19 - 50 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: